Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023.
Saved in:
| Title: | Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023. |
|---|---|
| Authors: | Hussain, Saira1 (AUTHOR) saira.hussain@influenzacentre.org, Meijer, Adam2 (AUTHOR), Govorkova, Elena A.3 (AUTHOR), Dapat, Clyde1 (AUTHOR), Gubareva, Larisa V.4 (AUTHOR), Barr, Ian G.1 (AUTHOR), Brown, Sook Kwan1 (AUTHOR), Daniels, Rod S.5 (AUTHOR), Fujisaki, Seiichiro6 (AUTHOR), Galiano, Monica5 (AUTHOR), Huang, Weijuan7 (AUTHOR), Kondor, Rebecca J.4 (AUTHOR), Lackenby, Angie8 (AUTHOR), Lewis, Nicola5 (AUTHOR), Lo, Janice9 (AUTHOR), Nguyen, Ha T.4 (AUTHOR), Patel, Mira C.4 (AUTHOR), Pereyaslov, Dmitriy10 (AUTHOR), Rattigan, Aine5 (AUTHOR), Samaan, Magdi10 (AUTHOR) |
| Source: | Antiviral Research. Sep2025, Vol. 241, pN.PAG-N.PAG. 1p. |
| Database: | Environment Complete |
Be the first to leave a comment!
